| | Optical coherence tomography in Barrett's esophagus: the road to clinical utilityWill gastroenterologists ever push the “OCT button” on their endoscopes to obtain clinically actionable images? Nine years ago in this journal, optical coherence tomography (OCT) was described as “the most noteworthy advance in diagnostic imaging of the GI tract” since the development of endoscopic US.1 In the time since, OCT has continued to develop, with a steady stream of articles describing applications and improvements. However, use of OCT remains largely investigational, and most studies involve technology not suitable for endoscopic delivery. Will gastroenterologists ever push the “OCT button” on their endoscopes to obtain clinically actionable images? What is the state of the revolution? In this issue of Gastrointestinal Endoscopy, Cobb et al2 investigate the ability of ultrahigh-resolution OCT to detect subsquamous intestinal metaplasia (SSIM) in 14 patients with biopsy-proven, high-grade dysplasia or adenocarcinoma. A GI pathologist had a 2-hour window to study each postesophagectomy esophagus with OCT and identify areas with a high probability of SSIM. Areas of concern for SSIM were tattooed and processed for histology, with the initial diagnosis confirmed by histology in all 14 specimens. The authors concluded that OCT is a viable imaging tool with a promising role in improving the surveillance of subsquamous and surface intestinal metaplasia. This study has several strengths. It addresses a highly clinically relevant problem for which we currently do not have a good solution: the detection of SSIM. Standard white light endoscopy does not detect nonnodular SSIM, and the prevalence and clinical importance of SSIM may increase as ablative therapies for Barrett's esophagus (BE) gain in popularity. Images were carefully matched in position and orientation to histology. The relationship of image to histology was independently assessed by 3 separate observers. Although the reliable performance of OCT in this study was impressive, the study methods also demonstrate several of the barriers to clinical implementation of the technology. The OCT system was mounted to a microscope platform, and each 1-mm by 0.6-mm image took approximately 12 seconds to obtain. Clearly, there is a difference between a pathologist taking hours to assess immobilized tissue on a bench-top and a time-limited gastroenterologist examining moving esophageal tissue in a sedated patient. Further, the technique of point sampling described in this protocol is limited by the same sampling error as random biopsy protocols, raising the question of whether we will see improvements in either diagnostic sensitivity or a cost-benefit advantage. The authors recognize that the study is bench-top research, a necessary step on the path to in vivo studies. The bigger question remains—how far are we from a tool that we can use every day? Does OCT have a role in the diagnosis and treatment of BE? OCT is a noncontrast, light-based imaging technique that produces high-resolution cross-sectional images by measuring backscattered infrared light. OCT produces a 2-dimensional, gray-scale representation of microscopic tissue architecture to a depth of 1 to 3 mm.3, 4 Several study groups are working to address issues of accuracy, speed, and ease of interpretation, with the goal of making OCT clinically relevant in gastroenterology. As yet, there is no wide-scale use of a commercially available OCT device. The potential for OCT in the evaluation and treatment of BE is apparent. Better imaging offers the possibility of comprehensive esophageal screening as opposed to the current protocol of systematic biopsy. Systematic, 4-quadrant biopsy has been shown to be a poor screening tool for dysplasia and subsquamous BE, because the distribution of dysplasia and buried glands is unpredictable and may involve only a small proportion of the BE segment.5, 6 OCT-detected atypia could, in turn, guide biopsies and/or therapy. Acquiring high-resolution images with detailed architectural information might eventually make “optical biopsy” feasible, possibly allowing for the complete replacement of conventional histopathology with imaging, while improving the accuracy of diagnosis and decreasing overall procedure time because of the omission of biopsies. The current work demonstrates that OCT has the capacity to localize and differentiate subsquamous pathology, suggesting that the technology might have particular utility in patients who have undergone ablative therapy.2 Getting from here to there: what are the qualities of a successful OCT device?  In order for OCT to fulfill its potential, the technology will need to satisfy several criteria. We envision at least 5 specific areas that will need to be addressed at the bench-top and in the endoscopy suite, to demonstrate the added value necessary for clinicians to adopt the new technology. High accuracy and biopsy concordance To improve on the current system of endoscopic surveillance—systematic, 4-quadrant biopsy every 1 to 2 cm, with standard white-light endoscopy—OCT will need to be sensitive and specific for dysplasia and subsquamous disease. In 2001, Poneros et al7 published the first study examining the accuracy of in vivo OCT in diagnosing Barrett's metaplasia and found a sensitivity of 97% and specificity of 92%. Although identification of intestinal metaplasia is useful, much current clinical decision-making in BE depends on the degree of dysplasia in the tissue. Subsequent work in the field has shown that the differences between OCT images of metaplasia and dysplasia are subtle. In 2005, Isenberg et al8 published a histological correlation study examining the accuracy of in vivo OCT in diagnosing dysplasia. They reported a sensitivity of 68%, specificity of 82%, and high interobserver variability. In 2006, Evans et al9 published a study further examining the OCT image characteristics of high-grade dysplasia and intramucosal adenocarcinoma. They created a 4-point scoring system based on histopathologic characteristics—a score of ≥2 had a sensitivity of 83% and specificity of 75% for high-grade dysplasia and/or intramucosal adenocarcinoma. Although the capacity for resolution has since improved,10 the sensitivity and specificity for dysplasia have not yet been studied in large numbers of participants at these higher resolutions. Large-area image acquisition The current system of systematic, 4-quadrant biopsy surveillance is limited by sampling error. In order to improve on the current system, OCT will need to quickly and accurately survey the distal esophagus. OCT images can be obtained in a linear or radial manner. Linear scanning produces a linear image and is able to sample only a small area at one time. Early studies of OCT obtained linear images and were limited by sampling error. Radial scanning creates an image similar to that seen in radial endoscopic US and has the potential for assessment of larger areas and thus may be more amenable to use in endoscopic surveillance. Recent studies have attempted to improve the capacity of OCT to obtain radial images. In 2008, Suter et al11 conducted a pilot study by using OCT in combination with a balloon-centering catheter to assess the feasibility of radial imaging of the distal esophagus. Of the 10 participants completing the study, 2 had incomplete visualization of the squamocolumnar junction because of malpositioning of the system. Although this device could perform a comprehensive survey of the distal esophagus, the balloon compressed the mucosa of the esophagus and, according to the authors, distorted the images significantly. Additionally, blood, mucus, motion artifact, and variations in balloon contact affected image quality. Given these issues, the authors felt that the sensitivity and specificity of diagnostic criteria developed for linear sampling OCT systems were not applicable to this radial OCT balloon system, and the sensitivity and specificity of radial OCT using this system are unknown. The balloon-centering system was not compatible with concomitant biopsy nor was the technique able to register 3-dimensional data for later localization of a potential biopsy site, making a study correlating images to histology impossible with that system. Fu et al12 conducted a similar pilot study by using OCT in combination with a balloon-centering catheter to assess the feasibility of large-area, comprehensive optical microscopy of the distal esophagus in swine. They reported that they were successful in imaging the distal esophagus. Unfortunately, the diagnostic capabilities, image quality, time to process the data, and the ability to perform biopsy concomitantly were not reported. Quick image acquisition The images obtained via OCT-guided surveillance of the distal esophagus will need to be obtained in a timely manner compatible with running an endoscopy suite and the risks of patient sedation. The rate of image acquisition has significantly improved in the last 6 years, with preservation of resolution.13 The improvement in speed has made comprehensive OCT of the esophagus possible. The two recent studies noted earlier imaged the distal esophagus and added, on average, only 4 minutes to the procedure.11, 12 Although the images were obtained quickly, the interpretation of the images occurred after endoscopy and was described as “time consuming and laborious.”11 Easy and efficient interpretation with low interobserver variability For the procedure to be clinically feasible, interpretation of OCT images will need to be easy, reliable, and efficient. Given the potentially large volumes of data that may be produced, we will need to develop a method to select clinically relevant images for review. The interpretation of high-risk images will require either a gastroenterologist trained in histopathology or a pathologist trained in OCT and/or an accurate diagnostic computer program. Qi et al14 attempted to address this issue with the development of a computer-aided diagnostic algorithm by using OCT to screen for dysplasia. The investigators created an image dataset with 106 high-quality OCT image-biopsy pairs obtained during endoscopic surveillance in 13 patients. They used this dataset to create a computer-aided diagnosis algorithm for the diagnosis of dysplasia. This algorithm demonstrated a sensitivity of 82% and specificity of 74%. However, OCT surveillance of the esophagus would generate thousands of images of various qualities. The authors report that their computer-aided diagnostic algorithm required human assistance to choose regions of interest and, therefore, would be unsuitable as a stand-alone device in a surveillance protocol. Cost effectiveness OCT systems are currently built by hand and adapted to the needs of a given research question. For wide-scale dissemination, a standardized, commercially available OCT system will be necessary, and it will come at a cost. What will that extra money buy? Will it eliminate the need for biopsy and histopathology, potentially paying for itself? Will it slow down the day in the procedure room, potentially costing money for something that is rapidly considered a standard part of endoscopy and not a separate line item? The economics are unclear. If OCT solves the problems of accuracy and easy image interpretation, what is the likelihood that it will improve patient outcomes? OCT may locate many lesions of unknown significance. For example, Cobb et al2 address the issue of SSIM. We have not yet established the natural history of SSIM, much less developed guidelines for management. Should the patient with current SSIM and previous dysplastic BE have recurrent ablation? Should they have more intensive endoscopic surveillance? Esophagectomy? No one knows. It is vital to isolate SSIM to answer these important research questions, but if the lesion turns out to be relatively benign, it may not end up being clinically relevant to making this diagnosis. Treatment guidelines for BE in general are conservative, with frequent surveillance intervals and aggressive treatment for precancerous lesions. Much effort goes into preventing a relatively rare cancer in a large pool of patients. If OCT turns out to be superior to current methods in stratifying risk, perhaps the greatest impact on cost-effectiveness will be to tell us who we do not need to worry about. Future directions: the role of advanced imaging in the shifting landscape of Barrett's esophagus  If the care of patients with BE moves toward earlier endoscopic intervention, including routine ablation of low-grade dysplasia or someday even nondysplastic intestinal metaplasia, what will this do to the utility of advanced imaging? Certain uses, such as highly accurate grading of noncancerous dysplasia, may become less important. Why concern ourselves with precise pathology if we are going to destroy it all, anyway? Other uses, such as finding SSIM, might become more important. Additionally, we may find that one or two of the many imaging systems currently in development best fit our changing needs. Several optical techniques are currently in development with the goal of improving the detection of esophageal pathology. These techniques, in addition to OCT, include chromoendoscopy, fluorescence spectroscopy, Raman spectroscopy, angle-resolved low-coherence interferometry, and confocal microendoscopy.3 The clinical relevance of OCT will also depend on its ability to cost-effectively fill an imaging niche before one of these other modalities. OCT has the potential to improve care in BE. To reach this potential, OCT will need to be accurate, efficient, reliable, user-friendly, and cost-effective. The ability to survey wide swatches of mucosa would also be beneficial. For widespread use of the technique, gastroenterologists would have to be trained in interpretation of OCT images, or an accurate computer algorithm to localize pathology will need to be developed. The ultimate clinical significance of this technology—how far it makes it down the road to clinical utility—depends on the ability of the technology to satisfy these needs. Disclosure  Dr. Shaheen disclosed the following financial relationships relevant to this publication: He receives research funding from Oncoscope, a developer of imaging technologies for the esophagus. He also receives research funding from BÂRRX Medical, and CSA Medical, makers of devices used in ablation of Barrett's esophagus. Dr. Peery disclosed no financial relationships relevant to this publication. References  1. 1Van Dam J, Fujimoto JG. Imaging beyond the endoscope. Gastrointest Endosc. 2000;51:512–516. Full Text |
Full-Text PDF (65 KB)
|
CrossRef
2. 2Cobb MJ, Hwang JH, Upton MP, et al. Imaging of subsquamous Barrett's epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study. Gastrointest Endosc. 2010;71:223–230. Abstract | Full Text |
Full-Text PDF (2536 KB)
|
CrossRef
3. 3Wilson BC. Detection and treatment of dysplasia in Barrett's esophagus: a pivotal challenge in translating biophotonics from bench to bedside. J Biomed Opt. 2007;12;. 4. 4Chak A, Wallace MB, Poneros JM. Optical coherence tomography of Barrett's esophagus. Endoscopy. 2005;37:587–590.
CrossRef
5. 5Chatelain D, Flejou JF. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Virchows Arch. 2003;442:18–24. MEDLINE 6. 6Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 1997;92:586–591. MEDLINE 7. 7Poneros JM, Brand S, Bouma BE, et al. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology. 2001;120:7–12. Abstract | Full Text |
Full-Text PDF (1796 KB)
|
CrossRef
8. 8Isenberg G, Sivak MV, Chak A, et al. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Gastrointest Endosc. 2005;62:825–831. Abstract | Full Text |
Full-Text PDF (321 KB)
|
CrossRef
9. 9Evans JA, Poneros JM, Bouma BE, et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4:38–43. Abstract | Full Text |
Full-Text PDF (205 KB)
|
CrossRef
10. 10Chen Y, Aguirre AD, Hsiung PL, et al. Effects of axial resolution improvement on optical coherence tomography (OCT) imaging of gastrointestinal tissues. Opt Express. 2008;16:2469–2485. 11. 11Suter MJ, Vakoc BJ, Yachimski PS, et al. Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc. 2008;68:745–753. Abstract | Full Text |
Full-Text PDF (1722 KB)
|
CrossRef
12. 12Fu HL, Leng Y, Cobb MJ, et al. Flexible miniature compound lens design for high-resolution optical coherence tomography balloon imaging catheter. J Biomed Opt. 2008;13;. 13. 13Vakoc BJ, Shishko M, Yun SH, et al. Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc. 2007;65:898–905. Abstract | Full Text |
Full-Text PDF (1826 KB)
|
CrossRef
14. 14Qi X, Sivak MV, Isenberg G, et al. Computer-aided diagnosis of dysplasia in Barrett's esophagus using endoscopic optical coherence tomography. J Biomed Opt. 2006;11;. Center for Esophageal Diseases and Swallowing, Division of Gastroenterology & Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA PII: S0016-5107(09)02543-7 doi:10.1016/j.gie.2009.09.034 © 2010 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. | |
|